Center "Vector" has received permission to conduct clinical trials of a vaccine against coronavirus, told in the press service of Rospotrebnadzor.
"The first volunteers will be vaccinated on 27 July," according to the report.
As noted previously the head of the government Mikhail Mishustin, the drug from COVID-19 in Russia are developing 17 scientific organizations, there are more than 26 types of vaccines. Deputy Prime Minister Tatiana Golikova called the "Vector" one of the leaders in the industry.
the Ministry of health are confident that the vaccine is effective to protect from infection. It is planned that the drug resistant forms long-lasting immunity, making the likelihood of re-infection is minimal.
During the entire period of the pandemic in Russia has identified about 800 thousand of cases COVID-19, 046 13 people died, more than 588 thousand recovered.
Current information on the situation of COVID-19 in Russia and the world presented on the portal stopmanager. Of the Russian Federation.
<span style="color:darkgray
sections: Politics |